Bank of America’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.56M | Buy |
263,356
+116,134
| +79% | +$1.57M | ﹤0.01% | 3579 |
|
|
2025
Q1 | $2.34M | Buy |
147,222
+39,519
| +37% | +$628K | ﹤0.01% | 3808 |
|
|
2024
Q4 | $1.33M | Buy |
107,703
+11,549
| +12% | +$142K | ﹤0.01% | 4037 |
|
|
2024
Q3 | $1.16M | Sell |
96,154
-15,381
| -14% | -$186K | ﹤0.01% | 4197 |
|
|
2024
Q2 | $1.3M | Buy |
111,535
+29,077
| +35% | +$340K | ﹤0.01% | 4030 |
|
|
2024
Q1 | $1.06M | Buy |
82,458
+33,703
| +69% | +$435K | ﹤0.01% | 4129 |
|
|
2023
Q4 | $419K | Buy |
48,755
+35,496
| +268% | +$305K | ﹤0.01% | 4736 |
|
|
2023
Q3 | $126K | Buy |
13,259
+1,030
| +8% | +$9.8K | ﹤0.01% | 5275 |
|
|
2023
Q2 | $209K | Sell |
12,229
-1,761
| -13% | -$30K | ﹤0.01% | 4978 |
|
|
2023
Q1 | $219K | Buy |
+13,990
| New | +$219K | ﹤0.01% | 5104 |
|